The attenuation of the 26th mouse brain passage of New Guinea C strain of dengue 2 virus for use in the sequential immunization procedure against group B arboviruses.
D000330:Aedes; D000818:Animals; D001102:Arbovirus Infections / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D001103:Arboviruses / Q000276:immunology; D001921:Brain / Q000382:microbiology / Q000473:pathology; D003168:Complement Fixation Tests; D046508:Culture Techniques; D003716:Dengue Virus / Q000276:immunology* / Q000302:isolation & purification; D000882:Haplorhini; D006385:Hemagglutination Inhibition Tests; D007279:Injections, Subcutaneous; D008251:Macaca; D051379:Mice; D002679:Pan troglodytes; D013116:Spinal Cord / Q000473:pathology; D014611:Vaccination; D014613:Vaccines, Attenuated / Q000008:administration & dosage; D014765:Viral Vaccines / Q000008:administration & dosage / Q000302:isolation & purification; D014774:Virulence; D014776:Virus Cultivation
D014613:Vaccines, Attenuated; D014765:Viral Vaccines